Structures of DPAGT1 Explain Glycosylation Disease Mechanisms and Advance TB Antibiotic Design.
Dong YY. et al, (2018), Cell, 175, 1045 - 1058.e16
LIMB GIRDLE SYNDROMES: MYASTHENIA OR MYOPATHY
Cruz PR. et al, (2016), Journal of neurology, neurosurgery & psychiatry, 87, e1.84 - e1
bicoid mRNA localises to the Drosophila oocyte anterior by random Dynein-mediated transport and anchoring.
Trovisco V. et al, (2016), Elife, 5
Late presentations of congenital myasthenic syndromes: How many do we miss?
Garg N. et al, (2016), Muscle nerve, 54, 721 - 727
Clinical features of the myasthenic syndrome arising from mutations in GMPPB.
Rodríguez Cruz PM. et al, (2016), J neurol neurosurg psychiatry, 87, 802 - 809
Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies.
Belaya K. et al, (2015), Brain, 138, 2493 - 2504
Congenital myasthenic syndrome caused by mutations in DPAGT.
Klein A. et al, (2015), Neuromuscul disord, 25, 253 - 256
Collagen Q--a potential target for autoantibodies in myasthenia gravis.
Zoltowska Katarzyna M. et al, (2015), J neurol sci, 348, 241 - 244
Collagen Q - A potential target for autoantibodies in myasthenia gravis
Zoltowska Katarzyna M. et al, (2015), Journal of the neurological sciences, 348, 241 - 244
Analysis of the expression patterns, subcellular localisations and interaction partners of Drosophila proteins using a pigP protein trap library.
Lowe N. et al, (2014), Development, 141, 3994 - 4005
Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1.
Finlayson S. et al, (2013), J neurol neurosurg psychiatry, 84, 1119 - 1125
Clinical features in a large Iranian family with a limb-girdle congenital myasthenic syndrome due to a mutation in DPAGT1
Basiri K. et al, (2013), Neuromuscular disorders, 23, 469 - 472
Clinical features in a large Iranian family with a limb-girdle congenital myasthenic syndrome due to a mutation in DPAGT1.
Basiri K. et al, (2013), Neuromuscul disord, 23, 469 - 472
Congenital myasthenic syndromes due to mutations in ALG2 and ALG14.
Cossins J. et al, (2013), Brain, 136, 944 - 956
Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1
Finlayson S. et al, (2013), Journal of neurology, neurosurgery and psychiatry, 84, 1119 - 1125
Congenital myasthenic syndromes due to mutations in ALG2 and ALG14
Cossins J. et al, (2013), Brain, 136, 944 - 956
Identification of DPAGT1 as a new gene in which mutations cause a congenital myasthenic syndrome.
Belaya K. et al, (2012), Ann n y acad sci, 1275, 29 - 35
The search for new antigenic targets in myasthenia gravis.
Cossins J. et al, (2012), Ann n y acad sci, 1275, 123 - 128
The spectrum of mutations that underlie the neuromuscular junction synaptopathy in DOK7 congenital myasthenic syndrome.
Cossins J. et al, (2012), Hum mol genet, 21, 3765 - 3775